| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |